NCT Number: NCT05128890
The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint.
The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Dallas, Texas, 75203, United States
Location status: Recruiting
Alejandro Mejia, MD
PRINCIPAL_INVESTIGATOR
Colette N Ndjom, MS
CONTACT
(214) 947-4681 ext. 71280
Jennifer Kirchner
CONTACT
214-947-4459 ext. 74459
The plan is to conduct a retrospective chart review of patients who have undergone pancreatic and liver resection by using Meditech and Epic. A non-identified database will be created after retrospectively reviewing each patient case involving pancreatic or liver resection at MDMC. The study period will start in January 2006 until December 2020. Variables will include demographics, clinical disease diagnoses, and operative parameters as well as indirect charges from the hospitalizations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
to compare open versus minimally invasive pancreatic resection techniques and analyze the different outcome variables from the clinical standpoint
Other names: minimally invasive pancreatic resection techniques
Time frame: through study completion, an average of 1 year
It will be calculated in days.Minimally invasive techniques are being adopted for complex pancreatic and liver surgery and there is a need to understand if these techniques are advantageous to the patient, if the cost is justified and if the risks are acceptable when compared to the gold standard open surgery.
Time frame: Up to 1 year
It will be calculated in days. The days stayed in hospital post-procedure.
Time frame: through study completion, an average of 1 year
Patient may visit physician or hospital for any symptoms or may need hospitalizations.
Time frame: up to 10 hours
The time required for the procedure.
Time frame: through study completion, an average of 1 year
If any post-procedure transfusion required, will be recorded.
Time frame: through study completion, an average of 1 year
After the procedure any hospital admissions up to 30 days will be recorded.
Time frame: through study completion, an average of 1 year
The hospital charges for the procedure will be recorded.
Contact information is provided by the study sponsor or research team.
Colette N Ndjom, MS
CONTACT
214-947-4681 ext. 74681
Jennifer Kirchner
CONTACT
214-947-4459 ext. 74459
Methodist Health System
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06929845
Adenocarcinoma, Carcinoma
Roma, Italy
View Trial DetailsNCT06939023
Cysts, Digestive System Diseases
Amsterdam, Netherlands
View Trial DetailsNCT06585072
Diabetes Mellitus, Digestive System Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06898398
Adenocarcinoma, Carcinoma
Beijing, Beijing Municipality, China
View Trial Details